Search
Search
Close this search box.

Love Hemp to appoint new AQSE corporate advisor 

Home » Love Hemp to appoint new AQSE corporate advisor 

Love Hemp is expected to appoint a new advisor in order to resume trading on the Aquis Stock Exchange (AQSE).

Love Hemp has stated it will be appointing a new AQSE corporate advisor following the resignation of Peterhouse Capital Limited. Peterhouse resigned following the failure of an investor in February 2022 to complete their investment of £1.2m.

Funds from the £2m February fundraise were to go towards general working capital purposes and streamlining the business through various initiatives. The transaction, for which H&P Advisory Limited and Peterhouse Capital Limited acted as brokers, was completed by way of a placing and subscription of 206,000,000 new ordinary shares of 0.1 pence each in the company at a price of 1p per share.

Read more: Love Hemp announces £4.33 revenue for 2021

Love Hemp’s board of directors has now begun an ongoing review of the events that led to the suspension in trading. Following its conclusion, any additional controls that are recommended will be put in place in order to prevent the potential for a similar issue occurring in the future.

Executive chairman and director, Andrew Male, commented: “The board are committed to protecting Love Hemp’s “best in class” brand reputation and the current board, strategic and operational review will ensure this is achieved.

“The board believes Love Hemp has significant growth opportunities and our review is designed to support this growth and enhance long term shareholder value.”

A board structure review is also being conducted by its independent non-executive director and two new board positions have been identified as being required. The company has stated it will immediately begin to look for a chief financial officer and another independent non-executive director.

Read more: Love Hemp CBD brand to launch on eBay

The company is also part way through an operational review and strategic review with the objective to accelerate profitable sales growth, as well as imposing additional rigour and governance on its operations and financial performance, and the company has stated that its board is committed to ensuring that this review is completed as quickly as possible and will be communicated to shareholders.

Love Hemp has recently seen an expansion to their collaborative trial with Deliver to deliver CBD products which started in January. The trial was originally only available in the Croydon area of South London but is now being extended to six new areas including Manchester. The brand was also recently one of the first to list on eBay’s UK platform, featuring Love Hemp’s sprays, drops and edibles.

[activecampaign form=31]

🔒 Risk Management Report • Produced in partnership with RELM
Prohibition Partners RELM
📊 New Report Available Now

Relm Risk Briefing: Cannabis 2026

The global cannabis sector has moved from experiment to enterprise. This comprehensive risk briefing examines how regulation, insurance, and operational practices intersect across the international supply chain, drawing on insights from RELM—the only insurer entirely dedicated to the cannabis industry.

What's covered

  • 🌱 Cultivation risk management — biological contamination, environmental instability, and security protocols
  • ⚗️ Manufacturing & extraction — GMP standards, in-house testing, and quality control measures
  • 🔬 Testing & compliance — rigorous protocols ensuring product safety and regulatory adherence
  • 📦 Distribution & logistics — GDP-aligned transport, route monitoring, and cargo insurance
Key focus areas
Cultivation Manufacturing Testing & QC Packaging Distribution Retail & Pharmacy
100% free • Comprehensive risk analysis

Key insights

Industry Maturity Cannabis has evolved from patchwork markets to international enterprise, with risk management now the measure of long-term stability.
Cultivation Challenges Operators addressing biological contamination through controlled-environment agriculture, tissue culture, and IPM protocols.
Quality Control GMP adherence, in-house testing, and selective supplier relationships emerging as critical control points.
Supply Chain Security GDP-aligned transport, route monitoring, and comprehensive insurance remain essential safeguards.
Market Access Initiatives stabilizing domestic supply and expanding pharmacy training improving patient and consumer access.
Produced by Prohibition Partners in collaboration with RELM—the only insurer dedicated to emerging industries like cannabis.
Partnership
Produced by Prohibition Partners in collaboration with RELM

Related Posts

Related Posts

CONNECT

Related Posts

Related Posts

Recent Posts

Related Posts

Subscribe to our mailing list to receives daily updates!

We won’t spam you

Categories

Browse by Tags

CATEGORIES

EDITION

BUSINESS OF CANNABIS

© 2023 Prohibition Holdings Ltd. All Rights Reserved.

EDITION

Are you sure want to unlock this post?
Unlock left : 0
Are you sure want to cancel subscription?